Maplight Therapeutics, Inc. · NASDAQ:MPLT
Nan Fung Group Holdings Limited reported a 5.50% stake in Maplight Therapeutics, Inc. (Schedule 13G)
Event Aug 13, 2026 · Filed Aug 20, 2026
Nan Fung Group Holdings Limited reported a 5.50% stake in Maplight Therapeutics, Inc., 2,915,874 shares, as a passive investor on Aug 13, 2026. Filed Aug 20, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 2,915,874
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nan Fung Group Holdings Limited | 5.50% | 2,915,874 |
| NF Investment Holdings Limited | 5.50% | 2,911,774 |
| Nan Fung Life Sciences Holdings Limited | 2.40% | 1,283,052 |
| NFLS Platform Holdings Limited | 1.30% | 671,606 |
| Pivotal Life Sciences Holdings Limited | 1.20% | 611,446 |
| Pivotal Partners Ltd | 1.20% | 611,446 |
| Pivotal bioVenture Partners Fund II G.P. Ltd | 1.20% | 611,446 |
| Pivotal bioVenture Partners Fund II, L.P. | 1.20% | 611,446 |
| NFLS Beta Limited | 1.30% | 671,606 |
| Permwell Management Limited | 3.10% | 1,628,722 |
Source
Related
- Maplight Therapeutics, Inc.
- Nan Fung Group Holdings Limited
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026